SLNO Soars 32.4%: Soleno Therapeutics Short Squeeze Talk?
SLNO stock surged 32.4% today, fueled by increasing short squeeze speculation for Soleno Therapeutics, the biotech behind Prader-Willi drug VYKAT XR.
In-depth NYSE & NASDAQ stock analysis with daily mover deep dives, catalyst breakdowns, technical setups, and sector context. Each ticker-level analysis combines real-time price action, news catalysts, and peer comparisons — built for active retail traders who need data-driven insights, not headlines.
In-depth NYSE & NASDAQ stock analysis with daily mover deep dives, catalyst breakdowns, technical setups, and sector context. Each ticker-level analysis combines real-time price action, news catalysts, and peer comparisons — built for active retail traders who need data-driven insights, not headlines.
29 articlesSLNO stock surged 32.4% today, fueled by increasing short squeeze speculation for Soleno Therapeutics, the biotech behind Prader-Willi drug VYKAT XR.
OIL surges 11.4% to $111.54 as Iran war risk escalates. Geopolitical tensions trigger cross-asset repricing ahead of jobs data. Energy leads markets.
USO surged 11.4% to $111.54 as Iran war escalation and Powell’s dovish pivot reignited the war premium, reshaping Fed rate expectations.
XLRE surged 1.61% today as falling yields created the perfect setup. Energy’s muted response to oil’s 11.4% spike reveals positioning problems.
PL stock surges 16.8% today on reports of significant margin expansion from revenue mix shift and automation improvements, trading on heavy volume.
SPX drops 0.84% and VIX spikes 6.52% as Pariah Capital’s Q1 win sparks risk-off amid geopolitical tensions. Energy surges 11.3%.
WTI crude oil surges 7.8% overnight, sending S&P 500 futures down 1.33%. Risk-off sentiment grips pre-market trading ahead of key levels.
SPX gained 0.72% but massive sector rotation saw Industrials surge 1.67% while Energy crashed -3.74%. Narrowing breadth signals potential market fragility.
GOLD futures spike +3.25% to $4,798.80 in pre-market, breaking resistance as safe-haven demand accelerates despite broader equity strength.